FDA Approves First Treatment for Geographic Atrophy Secondary to AMD Pegcetacoplan reduced GA lesion growth by 22% over 24 months versus sham injections Feb 18, 2023
Atropine Eye Drops Reduce Nearsightedness Incidence in Kids Whether effect represents a delay or prevention requires further study Feb 14, 2023
No Visual Acuity Benefit With Early Anti-VEGF for Diabetic Retinopathy "May not be worth the risk and inconvenience to the patient," researcher says Feb 07, 2023
CDC Sounds Alarm on Eye Drops Linked With Drug-Resistant Infection Permanent vision loss, death due to possible contamination leads to product recall Feb 02, 2023
The Eye Surgery Turf War Isn't Serving Veterans The VA should hold strong to its updated care guidelines Dec 28, 2022
FDA's Proposed LASIK Warning May Leave Patients Less Informed The agency's recommendations should balance risk with benefit Dec 21, 2022
Keep Eye Surgery in the Hands of Ophthalmologists The VA's updated eye care guidelines will lower the standard of care for veterans Dec 04, 2022
Four Eyes Are Not Better Than Two for COVID-19 Protection But wearing glasses can't hurt and may help, researchers say Dec 01, 2022
On Vision and the Arts Michael Marmor, MD, gives his perspective on our most important sense Nov 27, 2022 podcast
Sjogren's Responds to Cytokine Treatment, Early Data Show Phase II trial signals possible breakthrough for hard-to-treat illness Nov 10, 2022
Outpatient Centers Cautiously Open Doors to Surgery for People With Cardiac Devices Will those with CIEDs become regular patients at ambulatory surgery centers within a decade? Oct 25, 2022
Persistent Double Vision Follows Insidious Onset of Ptosis in Healthy Man High-resolution MRI aids in differential diagnosis Oct 10, 2022
AAO Roundup: Glaucoma Subtype Linked to Alzheimer's Disease Risk Other studies report fewer reoperations with combo eye surgery and vision risk with shingles Oct 06, 2022
Should Myopia Control Be Mainstream in the U.S.? Reducing the severity of nearsightedness can benefit public health Oct 05, 2022
Anti-VEGF Conjugate Gets a Win in Retinal Vein Occlusion Tarcocimab noninferior to aflibercept while cutting treatment burden in half Oct 04, 2022
Surgery Plus Stent Slows Glaucoma Progression Better Than Surgery Alone Five-year follow-up shows significantly less annual visual field progression with the stent Oct 04, 2022
Traditional Glaucoma Surgery Tops MIGS for Treatment Success Twice as many patients met IOP goals with TIGS, but confounders complicated data analysis Oct 03, 2022
Therapeutic Candidates for Dry AMD Move Closer to Clinical Practice Slowing of geographic atrophy at 1 and 2 years with pegcetacoplan, avacincaptad pegol Oct 03, 2022
Higher Dose, Longer Treatment Interval With Aflibercept Shows Promise in Eye Disease Dosing 8 mg every 12 or 16 weeks for DME, AMD matches results with 2 mg every 8 weeks Oct 02, 2022
What to Expect at This Year's American Academy of Ophthalmology Meeting Maria Aaron, MD, previews the programs and studies at the 2022 meeting in Chicago Sep 25, 2022 video
Incidence of Dry Eye Disease Lower With SGLT2 Inhibitors Retrospective study in Taiwan reported 22% risk reduction compared with GLP-1 receptor agonists Sep 24, 2022
Eye Damage Can Start in Prediabetes Study found significant corneal nerve damage even before full-blown type 2 diabetes Sep 22, 2022
Which Groups of U.S. Teens Are More Likely to Have Poor Vision? Worse subjective, objective outcomes among Black, Mexican-American, low-income adolescents Sep 15, 2022
Increased Health Spending When Private Equity Acquires Physician Practices Patient volume also increased, but whether patients are benefiting remains to be seen Sep 02, 2022
Most Patients With Neovascular Eye Disease Prefer Anti-VEGF Implant More than 90% of patients say they would choose implant over monthly intravitreal injections Aug 25, 2022
Oral Supplement for Childhood Myopia: Preliminary Data Promising Modest myopia progression with 7-methylxanthine, a caffeine metabolite Aug 23, 2022
What's Causing This Strange Constellation of Symptoms in an Older Woman? Prompt assessment and treatment needed to prevent blindness, authors warn Aug 08, 2022
FDA OKs First Interchangeable Ranibizumab Biosimilar When available, Cimerli qualifies for pharmacy-level substitution for reference drug Aug 03, 2022
Durable Vision Improvement With Light Therapy for Dry Macular Degeneration Also from ASRS: gene therapy for retinitis pigmentosa, anti-VEGF implant matches injection Jul 20, 2022
Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease Longer treatment-free interval with similar vision outcomes versus aflibercept in neovascular AMD Jul 19, 2022
Intravitreal Methotrexate Reduces Reoperation After Retinal Detachment Repair Reoperation rate reduced by three fourths, use expanded to advanced diabetic retinopathy Jul 18, 2022
Link Between Neovascular Eye Disease, CVD Tracked to Retinal Lesions Subretinal drusenoid deposits found in 85% of patients with AMD and CVD in small study Jul 16, 2022
Gene Therapy Shows Promise for Age-Related Macular Degeneration Reduced treatment burden, durable therapeutic effects with aflibercept-expressing construct Jul 15, 2022
'Senolytic' Therapy Shows Promise in Neovascular Eye Disease Clearing out dying cells, approach has implications far beyond ophthalmology Jul 14, 2022
Primary Care Screening Flops in Detecting Diabetic Eye Disease Fundoscopy screening had low sensitivity, accuracy in primary care setting Jun 28, 2022
Concerning Trends in Vision Impairment for Adults With Diabetes? Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
More Intense Pain Tied to Failed Appendicitis Treatment in Kids Study showed higher pain levels led to early failure in antibiotic treatment May 02, 2022
More Evidence That Fenofibrate Slows Diabetic Eye Disease Significant decline in progression to vision-threatening status, proliferative retinopathy Apr 26, 2022
Vision-Threatening Retinal Condition Linked to COVID-19 Rates of rare retinal vein occlusion jumped after infection, although overall numbers remain low Apr 14, 2022
ED Meds Linked to Higher Risk of Ocular Adverse Events Adjusted incidence rate ratio of 1.85 for three serious conditions with use of PDE5 inhibitors Apr 07, 2022
